Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance

Affiliations

• ¹ Department of Neurosciences, Drug and Child Health, University of Florence, Viale Gaetano Pieraccini, 6, 50139, Florence, FI, Italy.
• ² Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy.
• ³ Department of Neurosciences, Drug and Child Health, University of Florence, Viale Gaetano Pieraccini, 6, 50139, Florence, FI, Italy. luca.massacesi@unifi.it.
• ⁴ Tuscany Region Multiple Sclerosis Referral Centre, Neurology 2, University Hospital of Careggi, Florence, Italy. luca.massacesi@unifi.it.